Mitochondria-targeted cyclometalated iridium (III) complex for H2S-responsive intracellular redox regulation as potent photo-oxidation anticancer agent

Ben Liu,Xu Huang,Meng Hu,Zhiyin Chen,Wei Zhang,Yi Li
DOI: https://doi.org/10.1007/s00775-022-01957-0
2022-09-06
Abstract:Owing to the safety and low toxicity, photodynamic therapy (PDT) for cancer treatment has received extensive attention. However, the excess H 2 S in cancer cells reduces the PDT efficiency, because H 2 S indirectly depletes the reactive oxygen species (ROS). To improve anticancer efficiency, a mitochondria-targeted iridium(III) complex Ir-MMB has been developed as H 2 S consumer and photo-oxidation anticancer agent. On the one hand, complex Ir-MMB can consume H 2 S with sensitive phosphorescence turn-on, which has been successfully applied to exogenous and endogenous H 2 S response imaging in living cells. On the other hand, Ir-MMB can enhance its anticancer activity and cause photo-oxidation damage via catalyzing the oxidation of reduced form of nicotinamide-adenine dinucleotide (NADH) to NAD + and producing H 2 O 2 under light, and ultimately results in cell apoptosis through mitochondrial depolarization and ROS production.
chemistry, inorganic & nuclear,biochemistry & molecular biology
What problem does this paper attempt to address?